Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-005749
Filing Date
2015-04-13
Accepted
2015-04-13 11:34:59
Documents
1
Period of Report
2015-04-09

Document Format Files

Seq Description Document Type Size
1 rrd424259.html 4  
1 rrd424259.xml 4 4114
  Complete submission text file 0001181431-15-005749.txt   5657
Mailing Address C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
FLANAGAN ROBERT J (Reporting) CIK: 0001251512 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 15766083

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations